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ABSTRACT
pilepsy is an important public health problem 
particularly in developing countries with 
limited resource. Globally, its prevalence varies E
1, 2
between 4.0 and 10 per 1000 population,  and has been 
reported to account for 60% of chronic neurological 
conditions seen in a tertiary paediatric neurology clinic 
3
in Enugu, South East Nigeria,   as well as one of every 
three children presenting at a paediatric neurology 
4
service in Ibadan, South West Nigeria.  
Poor compliance to treatment is a major factor affecting 
seizure control as well as quality of life of children with 
epilepsy. Approximately 30% - 70% of patients with 
chronic illnesses like epilepsy, asthma and diabetes 
have poor compliance/adherence to treatment as a 
result of the psychological, educational and social 
 5, 6
problems which surround these chronic illnesses.
Several factors have been linked to poor compliance 
including extended treatment duration, periods of 
symptomatic remission, high cost of treatment, a shift 
in physician-patient relationship as well as medication 
related issues such as multiple medications, 
acceptability and palatability of the drug form, and 
6,7
adverse effects of the medication.  In resource limited 
settings like ours, high rates of  low  socio economic 
status including  low  literacy levels and poverty; social 
customs and cultural beliefs; high rates of social 
stigmatization further compound  the problem of 
8, 9, 10
compliance among children with epilepsy.  The 
cultural beliefs that epilepsy is caused by supernatural 
powers, evil spirits, extremes of heat and cold,  
inhalation of bad air, contact with bad saliva and urine 
adversely affect compliance of children with epilepsy 
to treatment as caregivers seek traditional 
complementary and alternative medical care (CAM) 
either prior to initial presentation to hospital or in  
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Case definitions:
A seizure is defined as a paroxysmal time-limited 
change in motor activity and/or behavior that results 
15
from abnormal electrical activity in the brain.
Epilepsy is defined as two or more unprovoked 
seizures occurring at an interval greater than 24 hours 
apart or one unprovoked (or reflex) seizure and a 
probability of further seizures similar to the general 
recurrence risk (at least 60%) after two unprovoked 
seizures, occurring over the next 10 years or an 
16, 17
epileptic syndrome.  
An epileptic or epilepsy syndrome is a cluster of 
seizures, other symptoms, physical signs and 
laboratory findings, which are associated in a non-
fortuitous manner. Identification of an epileptic 
syndrome requires clinical findings (type of seizure, 
age at onset, precipitating factors, severity and 
chronicity, circadian distribution, aetiology, 
anatomical location and prognosis) and data from 
ancillary studies (electro-encephalogram (EEG), brain 
anatomical and metabolic imaging, haematology and 
14
biochemistry).
The seizure types were classified based on the ILAE 
18, 19
classification of epilepsy and epileptic syndromes.
Inclusion Criteria:
All paediatric patients who were aged 1 to 18 years old 
diagnosed with epilepsy/ epilepsy syndrome from 
h i s t o r y ,  c l i n i c a l  e x a m i n a t i o n ,  a n d  
Electroencephalogram (EEG) with or without 
computerized tomography scan (CT scan) and 
biochemical tests who had attended Paediatric 
Neurology Clinic of the University of Nigeria Teaching 
Hospital, Enugu for at least 6 months were the subjects 
of this study.
Exclusion Criteria:
Newly diagnosed patients with epilepsy as well as 
confirmed cases of other neurological disorders other 
than epilepsy or epileptic syndrome; children with 
single or isolated seizure, febrile or other provoked 
seizures; and patients who have been on remission not 
requiring antiepileptic drug were excluded.
Ethical Considerations:
Ethical approval for the study was obtained from the 
Health Research and Ethics Committee of the UNTH, 
Enugu. The objectives and details of the study were 
explained to patient's mothers/ caregivers, and older 
patients in a language that is well understood by them. 
Informed verbal consents were obtained from the 
patient's mothers/ caregivers, and assent was obtained 
from the children who were old enough to give 
7,8,11
between periods of treatment.  The resultant effect is 
that patients present late to the clinics with some 
manifesting evidence of mental retardation and 
incapacitation requiring complete dependence on a 
caregiver to maintain the minimal level of quality of 
12
life.
Generally, poor compliance could lead to poor seizure 
11
control  due to inadequate or unsuccessful therapy 
further reducing the quality of life of the sufferer. It 
creates room for unnecessarily extended treatment, 
additional clinic follow up visits, and change of 
medication regimen in order to improve their clinical 
13
condition.  Good treatment compliance in children 
with epilepsy will ensure adequate seizure control, 
improved academic performance as well as overall 
14
quality of life.
Hence, the study was aimed at determining the factors 
affecting compliance to treatment among children with 
epilepsy attending the Paediatric Neurology Clinic 
University of Nigeria Teaching Hospital (UNTH), 
Ituku-Ozalla, Enugu, South East Nigeria 
         
Methods
Study setting: 
The paediatric neurology clinic is a weekly (Friday) 
clinic with full complement of staff. There are 3 trained 
paediatric neurologist, 2 senior registrars, and 3 
registrars running each clinic day. Other support staff 
are the medical records officers who sort out patients' 
folders. Services rendered are mainly clinical. 
Electroencephalography is performed by trained EEG 
technicians on requests by attending neurologist. Other 
ancillary services provided are physiotherapy, speech 
therapy. Ophthalmology, Otorhinolaryngology and 
psychiatry consults are sought based on individual 
patient need etc. Children who require specialized 
education are referred to centers that offer such 
services.                   
Study Population:
Paediatric patients from 6 months to eighteen years old 
with neurological disorders such as post infectious 
neurological deficits, developmental delays, epilepsy 
or epileptic syndrome; behavioral disorders, pervasive 
disorders, children with single or isolated seizure, and 
recurrent febrile seizures make up the study 
population.
Study design:  
This was a combined retrospective and prospective 
cohort study conducted over a 9 month period (1stJuly 
2012 to 31st March 2013) in which patients with 
epilepsy who met the inclusion criteria were 
consecutively enrolled.




Chi–square was used to test for statistically significant 
associations between variables. The level of statistical 
significance was set at p < 0.05. 
Results
A total of 56 patients (36 males and 20 females) aged 
between 2 years to 18 years old (mean age: 9.7 ± 4.1 
years) were studied. Twelve (21.4%) of the 56 patients 
were of the upper social class (I and II), 18 (32.1%) 
middle class (III), while 26 (46.4%) belonged to the 
lower class (IV and V), as shown in Table 1. 
information about their conditions.
Data Collection
Relevant data was collected on each of the recruited 
patients using a standardized structured interviewer 
2 0
administered questionnaire  by one of the 
investigators. Data collected include: socio-
demographic characteristics including name, age, 
gender, religious inclination, highest educational 
attainments as well as the occupation of the parents 
from where the socioeconomic class was determined 
21
using the method proposed by Oyedeji.  Other 
information obtained included clinical diagnosis, co- 
morbid medical conditions; spiritual illusion or 
thoughts of parent/caregiver about epilepsy; 
electroencephalographic and/ or CT scan report; 
seizure frequency; previous history of seizures 
including frequency and treatment received, treatment 
given in the neurology clinic, drug dosages, doses 
missed, compliance to drug regime/administration, 
adverse effects attributable to the drugs, any change in 
drug regimen, accessibility of drugs, duration of follow 
up/ period of default (default was defined as being 
more than 1 month late for the next scheduled 
22
appointment);  history of seizure recurrence and 
seizure frequency during discontinuation of treatment. 
Patients were followed up after enrollment for a period 
of 1 month during which additional information on 
seizure frequency during follow up was obtained. 
Drugs were supplied in a container and patients/ 
parents were advised to adhere strictly to prescription 
given. They were instructed to return the container and 
the remaining drugs during the next visit.
Measurement of Compliance and Seizure control:
Compliance was measured by the patient/ parent 
reported adherence to prescription in a questionnaire 
as well by pill counting. Patients were considered good 
compliers if they admitted to have taken their drugs as 
prescribed within the 7 months under review (last 6 
months before the study and 1 month during the 
study), had not missed out-patient clinic visits more 
than once, and compliance was confirmed if they took > 
20
85% of the medications prescribed for one month.
Patients were considered controlled if they had two or 
fewer seizures during 7 months of known seizure 
treatment (i.e. last 6 months before the study; and 1 
20
month during study)  and uncontrolled if they had  3 
or more attacks during this period.
Data Analysis
The data obtained was analyzed with the 
computerized IBM Statistical Package for Social 
Sciences (SPSS) version 20 (IBM Chicago Illinois, USA). 
Characteristics were presented as frequency tables. 
Table 1: Socio-demographic characteristics of 56 
participants
 Frequency (n)  Percentage (%)
Age 
 























































The most frequent type of epilepsy was the generalized 
tonic clonic epilepsy occurring in 23/56 (41.1%) of 
patients followed by the mixed epilepsy seen in 9 (16%) 
of cases, and then complex partial seizure occurring in 7 
(12.5%) of cases. The mixed epilepsy was a combination 
of generalized tonic clonic seizure with any of the 
following: complex partial, focal with secondary 
generalization, absence, atonic, or myoclonic seizures. 
One patient had infantile spasm, as displayed in Table 
2. 
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Table 2: Types of Epilepsy based on Clinical 
Diagnosis among 56 participants
Type of Epilepsy  Frequency (n) Percentage (%)
































Forty (71.4%) respondents did not know the possible 
causes of epilepsy; 13 (23.2%) responded to other 
causes such as hereditary, fever, brain trauma, brain 
tumor, malaria, breech delivery, transfusion of 
unscreened blood; 4 (7.1%) respondents feel epilepsy is 
caused by a combination of factors including anger of 
the ancestral spirits, evil spirit, extremes of heat and 
cold, and witches/wizards.
Twenty six (46.4%) sought treatment at various private 
clinics before presentation; 10 (17.9%) did not seek any 
form of treatment; 8 (14.3%) sought and received herbal 
medication; 7 (12.5%) resorted to prayers; 2 (3.7%) 
visited traditional healing homes. Only one respondent 
offered sacrifices to the gods. 
The antiepileptic drugs used in treating these patients 
include- phenobarbital, carbamazepine, sodium 
valproate, phenytoin, nitrazepam and clonazepam. 
Carbamazepine was the most frequently used drug. 
The drugs were very accessible to about 89.3% of 
patients. Only 6 out of 56 patients experienced 
difficulty accessing their drugs. Three of them were on 
Tegretol-control release while the other 3 were on 
sodium valproate (Epilim). 
 A total of 36 (64.3%) respondents complied strictly with 
the treatment regimen while 20 (35.7%) were not 
compliant (p<0.001). Of these 20 who were not 
compliant, 14 had reasons for not being compliant 
(Table 3). The remaining 6 had no reasons. Thirty four 
(60.7%) patients were on single therapy; 22 (39.3%) 
were on multiple regimen (ranging between 2 to 4 
drugs).
Table 3: Factors responsible for non-compliance 
among the 20 participants who did not comply 
with treatment
Reasons  No. of patients (n)  Percentage (%)






























Twenty four of 34 patients (70.6%) on single therapy 
and 12 of 22 patients (54.5%) on multiple drugs were 
compliant; 10 patients on single therapy and 10 patients 
on poly-therapy were not compliant as shown in Table 
2
4 (c= 1.497; p>0.05). 
Table 4: Relationship between Mode of therapy and 
Compliance among 56 participants
 Compliant  





 Therapy   
  




10 (29.4) 34(100)              
Multiple                                  12 (54.5) 10 (45.5) 22 (100)            
Total 36 (64.3) 20 (35.7) 56 (100)
2c=1.497; P= 0.262
About 76.2% of patients on twice daily dosing were 
compliant; Only 28.6% of patients on three times daily 
2dosing were compliant (c= 10.370; p<0.05 ), Table 5. 
Table 5: Relationship between Drug Dosing and 
Compliance among 56 participants
 Compliant  
n (%)
 








   






42 (100)        
Thrice daily





14 (100)            
Total 36 (64.3) 20 (35.7) 56 (100)
2c=10.370; P= 0.001 (significant)
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were satisfied with the level of care being received at 
the clinic. 
DISCUSSION
Epilepsy is a common chronic neurological disorder of 
childhood in our setting with generalized tonic clonic 
epilepsy being the most frequent type observed in the 
current study. Similar studies have been reported in 
Nigeria where the generalized tonic clonic form of 
epilepsy constitutes about 25 to 65% of the cases 
23
studied.
The knowledge of the common cause/s of epilepsy was 
poor among the caregivers of the children in the current 
study. Evil spirit and supernatural powers were 
believed to be the cause of epilepsy in about 5.4% of 
them.  This compares favourably with findings from 
other authors who documented a strong belief that 
7, 9
epilepsy was caused by these forces.   
This belief is reflected in the health seeking behavior of 
the parents/caregivers. In this study, 46.4% sought 
orthodox treatment at secondary health facilities 
(private hospitals) before presentation to our clinic 
which is a tertiary center. More than 30% sought 
different complementary and alternative (CAM) 
treatment before presentation including herbal 
medication and prayers while 17.9% did not seek any 
form of treatment probably out of ignorance of the 
disease and its treatment or for fear of stigmatization. 
These findings have been corroborated by other 
7
workers.  Half of the patients studied by Sureka and 
7
Sureka  had tried alternative treatments before 
presentation to the clinic.
Poor compliance was a serious problem among our 
5,24
patients. Consistent with other studies  a significant 
proportion (35.7%) of the children in the current study 
was not compliant to treatment. Epilepsy sufferers 
become non adherent or discontinue treatment due to 
several socioeconomic factors and suffer from seizures 
6, 9 
repeatedly. Factors that affected level of treatment 
compliance among the patients studied were high cost 
of drugs; long period of treatment; multiple 
medications and associated side effects. The out- of- 
pocket expenses for patients with epilepsy in many 
developing countries are quite enormous due to lack of 
well established health insurance scheme and lack of 
25,26
adequate social security structure.  In Nigeria, the 
national health insurance scheme established about 10 
years ago is still not universal as only workers in federal 
and a few state and organized private sectors are 
currently accessing its services. Most (94.6%) of the 
children studied had no form of health insurance and 
their parents had to pay for their treatment 
(consultation, drugs, investigation and so on) from 
Seizure control among patients on single therapy was 
compared with that of patients on poly- therapy. 
Twenty seven (79.4%) of 34 patients on single therapy 
had good seizure control while only 6 (27.2%) out of 22 
2
of patients on poly-therapy were controlled (c= 15.003; 
p<0.001).                           
Thirty seven patients (66%) were not experiencing any 
form of side effects; 19 (34%) were experiencing side 
effects. Of the 19 who had side effects, 17 listed the 
specific side effects. Most common side effect noted 
was excessive sleep (5/56, 8.9%). Others were dizziness 
(2/56, 3.6%), hyperactivity (2/56, 3.6%), skin rash 
(2/56, 3.6%), weight gain (2/56, 3.6%). The least side 
effects were forgetfulness, generalized weakness, jerky 
movements, and stomach pain listed by four patients. 
Majority (25/37, 67.5%) of the patients who did not 
experience any side effects were on single therapy. 
Compliance was better among those who did not 
experience side effects- (26/37, (70.3%) compared with 
(10/19, 52.6%) who experienced side effects being 
compliant. 
Most (38/56, 67.8%) patients had their drug 
administered by an adult who is either a parent or a 
member of the family. Compliance was better when a 
2
parent or caregiver administered the drug (c= 2.188; 
p>0.05). Differences in social class did not affect 
patients' level of compliance or non- compliance ( = 
0.764; p>0.05).
Rate of Default and Reasons for Default: 
Our participants had been attending the neurology 
clinic for a period of 6 months to 168 months (mean 87 
months), average number of visits was 6 visits per year; 
a few patients had about 8 to 12 visits/ year due to poor 
seizure control. Forty three percent (24/56) of the 
patients had defaulted follow up more than once since 
admission into the clinic; period of default was 
between 3 months and 4 years; 71% continued 
treatment at home while 29% discontinued treatment.
Reasons for default were domestic such as 
bereavement; caregiver being ill or having to take care 
of a sick relative; financial constraint; prolonged period 
of therapy and poor seizure control with feeling of 
hopelessness, preference for spiritual healing.  Three 
defaulted because seizures were controlled within the 
period.  
Significant positive attitude changes were noticed 
following education of the patients and their families. 
On follow up one month after enrollment into this 
study, compliance improved from 64.3% to 87.5% 
based on patients taking > 85% of medication 
19
prescribed.  Most of the parents/caregivers (96.4%) 
2c
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dysfunction, increased with the number of AEDs 
prescribed. Improved compliance and reduction in the 
number of patients with intolerable side effect from 
15% to 9% were observed when the number of patients 
on poly-therapy was reduced from 60% to 45% in an 
7
Indian study.  Thus, it is important to balance adequacy 
of seizure control with the patient's quality of life.
Differences in social class did not affect our patients' 
level of compliance or non- compliance as more of the 
compliant as well as non -compliant patients were from 
low socioeconomic class contrary to the study that 
linked poor compliance with low socioeconomic status 
36
on one hand;  and another with high socioeconomic 
37
status.  
The average number of visits per patient was 6 visits 
38
per year. Gopinath and colleagues  observed that both 
the number of visits and effective communication 
between the doctor and the patient promoted 
adherence as multiple visits to the doctor enhanced 
communication and better compliance behavior 
among their patients. Level of care was not a 
contributory factor to poor compliance in our patients 
as most (96.4%) of the participants in this study were 
satisfied with the level of care being received at the 
clinic. Parent and child satisfaction with medical care 
has a positive influence on patients' adherence to 
39, 40 
treatment.
Forty three percent of the patients studied had 
defaulted to follow up more than once since admission 
into the clinic with periods of default ranging between 
3 months and 4 years; 29% of them did not continue 
medication as prescribed during the period of default. 
7
Similarly, Sureka and Sureka  noted that 37% of their 
patients did not attend the clinic regularly. Reasons for 
default in our patients were domestic: bereavement; 
caregiver being ill or having to take care of a sick 
relative; financial constraint; prolonged period of 
therapy and poor seizure control; faith in spiritual 
healing; and periods of symptomatic remission. This 
9, 12 
finding have been corroborated by other workers.
Significant positive attitude changes were noticed 
following education of the patients and their families. 
Compliance improved from 64.3% to 87.5% based on 
patient/parent reported adherence and pill counting. 
7
Sureka and Sureka  also reported that the number of 
patients who missed their medication was reduced by 
half following education of patients and their families. 
CONCLUSION
Poor compliance to medication is a major problem 
among children with epilepsy in our setting. The cost, 
number, frequency of dosing, and side effects of 
medications remain important factors that determine 
27
their pockets. Lagunju et al  also documented that 
94.4% of the children studied had no form of health 
insurance and more than half of the families expended 
over 20% of their total family income on the care of the 
child with epilepsy. Institution of a well organized 
health insurance scheme in Nigeria will go a long way 
in reducing the cost of treatment of epilepsy among our 
children.  
27, 28
Consistent with other studies,  compliance was 
27
better with single therapy than poly therapy. Leppik  
noted that non- compliance increased with multiple 
medications when patients  misunderstood 
instructions for using prescribed medications. Majority 
of our patients on single therapy had better seizure 
control than those on poly-therapy (79.4% compared 
with 27.2%). It has been documented that 60-80% of 
patients with epilepsy can be well controlled with one 
28
appropriately chosen drug.  However, a few of the 
patients with poor seizure control may require 
additional AED drug to achieve good control. 
Some of the patients (35%) reported forgetfulness as 
their reason for poor compliance. The issue is whether 
the number of medications the patient needed to take 
indirectly determines his level of commitment to take 
29
them. Cramer and colleagues  argued that the number 
of medications was not a factor affecting adherence 
because once a patient remembered he was due to take 
a dose, he took them all at the same time. On the other 
hand, the number of daily doses also affected 
compliance. Patients with less frequent doses complied 
better than those with multiple doses of drugs. About 
76.2% of our patients on twice daily dosing were 
compliant while only 28.6% of those on three times 
daily dosing were compliant. Adherence rates have 
been noted to be significantly higher in patients using 
30 31
less frequently dosed medication.  Cramer et al  
observed that the number of daily doses was the most 
consistent predictor of non- compliance with AED 
treatment and an increased risk of seizure; and the odds 
of missing a dose increased by 27% each additional 
32
time a drug was expected to be taken.  In order to solve 
this problem, use of sustained-release (SR) 
formulations that enable once or twice daily dosing and 
have additional advantage of giving fewer side effects 
33 
have been advocated
The most common side effect noted among the 
participants in the current study was excessive sleep. 
34
Similarly, Martins et al  documented sleepiness as the 
most frequent side effect among their patients. 
Compliance was more among those that did not 
experience any form of side effect; 67.6% of them were 
35
on single therapy. Brodie  also noted that the 
likelihood of toxic effects, especially cognitive 
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